Predicting problems does absolutely nothing unless you have created a solution to prevent the problem! I don't see that here, so useless research!
Predictors of severe intracerebral hemorrhage expansion
Abstract
Background:
Severe
hematoma expansion (sHE) has the strongest impact on intracerebral
hemorrhage (ICH) outcome. We investigated the predictors of sHE.
Methods:
Retrospective
analysis of ICH patients admitted at nine sites in Italy, Germany,
China, and Canada. The following imaging features were analyzed:
non-contrast CT (NCCT) hypodensities, heterogeneous density, blend sign,
irregular shape, and CT angiography (CTA) spot sign. The outcome of
interest was sHE, defined as volume increase >66% and/or >12.5
from baseline to follow-up NCCT. Predictors of sHE were explored with
logistic regression.
Results:
A
total of 1472 patients were included (median age 73, 56.6% males) of
whom 223 (15.2%) had sHE. Age (odds ratio (OR) per year, 95% confidence
interval (CI), 1.02 (1.01–1.04)), Anticoagulant treatment (OR 3.00, 95%
CI 2.09–4.31), Glasgow Coma Scale (OR 0.93, 95% CI 0.89–0.98), time from
onset/last known well to imaging, (OR per h 0.96, 95% CI 0.93–0.99),
and baseline ICH volume, (OR per mL 1.02, 95% CI 1.02–1.03) were
independently associated with sHE. Ultra-early hematoma growth (baseline
volume/baseline imaging time) was also a predictor of sHE (OR per mL/h
1.01, 95% CI 1.00–1.02). All NCCT and CTA imaging markers were also
predictors of sHE. Amongst imaging features NCCT hypodensities had the
highest sensitivity (0.79) whereas the CTA spot sign had the highest
positive predictive value (0.51).
Conclusions:
sHE
is common in the natural history of ICH and can be predicted with few
clinical and imaging variables. These findings might inform clinical
practice and future trials targeting active bleeding in ICH.
Introduction
Intracerebral
hemorrhage (ICH) is one of the deadliest types of stroke, with high
short term mortality and severe neurological sequelae in the majority of
survivors.1
Hematoma expansion (HE) is a potentially preventable determinant(Useless statement without the EXACT PROTOCOL THAT WILL PREVENT THIS EXPANSION!) of
poor outcome and represents therefore a compelling therapeutic target.2
However, the HE-outcome relationship is not linear, and only severe HE
(sHE), defined as hematoma volume increase >66% and/or >12.5 mL,
has a significant prognostic impact.3
Previous studies and prediction models focused on the more commonly
used definition of HE (volume increase >33% and or >6 mL), whereas
predictors of sHE remain poorly characterized.4 We aimed to describe the clinical and imaging variables associated with sHE.
More at link.
No comments:
Post a Comment